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Background/Aims: The response to the liver damage caused by portacaval shunt (peS) is characterized by low-grade 
hyperplasia and atrophy. To clarify mechanisms of this dissociation, we correlated the expression of 'hepatotrophic 
factors' and the antihepatotrophic and proapoptotic peptide, transforming growth factor (TGF)-I}, with the pathologic 
changes caused by pes in rats. 
Methods: pes was created by side-to-side anastomosis between the portal vein and inferior vena cava, with ligation of 
the hilar portal vein. Hepatic growth mediators were measured to 2 months. 
Results: The decrease in the Iiverlbody weight ratio during the first 7 days which stabilized by day 15, corresponded 
to parenchymal cell apoptosis and increases in hepatic TGF -I} concentration that peaked at 1.4 X baseline at 15 days 
before returning to control levels by day 30. Variable increases in the concentrations of growth promoters (hepatocyte 
growth factor, TGF -0( and augmenter of liver regeneration) also occurred during the period of hepatocellular apop-
tosis. 
Conclusions: The development) of hepatic atrophy was associated with changes in TGF-I} concentration, and 
occurred despite increased expression of multiple putative growth promoters. The findings suggest that apoptosis set 
in motion by TGF-I} constrains the amount of hepatocyte proliferation independently from control of liver volume. 
© 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved. 
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1. Introduction 
Portacaval shunt (peS, also known as Eck's fistula LID 
and partial hepatectomy (PH) are experimental operations 
that have opposite effects on liver size. Eck's fistula has 
been a model of liver atrophy for more than 100 years l2]. 
The shrinkage of the liver is accompanied by a tripling of 
steady state hepatocyte renewal that stabilizes after 4-7 
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days in rats, dogs, pigs and baboons l31. Interestingly, 
however. the side effects of pes (originally termed 'meat 
intoxication' [2]) that cause the death of dogs, baboons and 
swine within several weeks are much less marked, or 
frequently may not be clinically apparent. in rats and 
humans [3-6J. In contrast to the hepatocyte atrophy of 
pes, PH causes acute hypertrophy and high grade hyper-
plasia of hepatocytes of the residual fragment and has been 
used to study liver regeneration in a variety of species l7,8] 
ever since the procedure was standardized in rats by Higgins 
and Anderson [9J. 
Despite the ostensibly great differences between pes and 
PH, both operations set in motion interactions between 
most, if not all, the same 'hepatotrophic' factors: i.e. hepa-
tocyte growth factor (HGF), transforming growth factor-a 
(TGF-a). insulin-like growth factor (IGF)-II, augmenter of 
liver regeneration (ALR) and insulin [10]. All five of these 
endogenous factors prevent the atrophy of pes when 
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infused in appropriate doses into the detached portal vein at 
the hilum following complete PCS [Ill. As was first demon-
strated with insulin [121, these molecules initiate prolifera-
tion in the Eck fistula liver beyond the preexisting low-grade 
hyperplasia resembling in magnitude the burst of regenera-
tion that follows PH. The hepatotrophic effects of active 
molecules are so reliably reproducible that an Eck fistula 
infusion assay has been used to screen the same liver growth 
factors that can be identified more laboriously with assays 
based on PH 1ID-12]. Importantly, both Eck fistula and PH 
assays also recognize the only known endogenous antihe-
patotrophic molecule transforming growth factor-13 (TGF-
13) [10,11,13]. 
Except for insulin, all of the endogenous hepatotrophic 
molecules, as well as TGF-I3, have multiple sites of synth-
esis, including the liver [7,8]. Thus, it is conceivable that the 
liver could autoregulate its size or regeneration by the auto-
crine or paracrine actions of these peptides. This view is 
consistent with, but not proven by, the changes that occur 
after PH in the hepatic mRNA and protein expression of 
HGF [14,15], TGF-CI' [J6.17J and ALR [18]. Furthermore, 
it has been reported that the peak increases in TGF-[3 mRNA 
coincide with the termination of regeneration prompting 
speculation that this molecule is the prime determinant of 
the reconstituted liver's ultimate size [7,8,19]. Because 
members of the TGF-13 superfamily are proapoptotic [20-
23], we have postulated that programmed cell death is an 
important mechanism in regulating liver growth and regen-
eration [18]. 
We report here peptide concentrations and the mRNA 
levels in the liver of the hepatotrophic molecules HGF, 
TGF-CI' and ALR following PCS. The patterns of change 
were similar to those caused by PH. However, because the 
increases in TGF-13 peptide concentration corresponded 
closely to apoptosis of the atrophic liver cells, the apoptotic 
effects of TGF-13 (and presumably the TGF-13 superfamily 
[20-23]) were correlated with hepatic proliferation and 
occurred independently of liver volume. 
2. Materials and methods 
The protocols were approved by the IACUC, University of Pittsburgh in 
accordance with the guidelines of the NIH. Inbred male Lewis rats (200-
250 g), purchased from Harlan Sprague Dawley Inc. (Indianapolis, IN, 
USA), were maintained in a laminar-flow, pathogen-free animal facilities 
at the University of Pittsburgh. Animals were kept at 20DC with a 12: 12 h 
light-dark cycle. and fed ad lihitllm. 
2.1. Surgical procedures 
Surgical procedure was performed on preweighed rats under methoxy-
flurane anesthesia. Laparotomy was perfonned and hepatoesophageal 
plexus was ligated. Side-to-side anastomosis was created between the portal 
vein and inferior vcna cava using 10-0 Novafil suture as described hy Lee 
and Fisher l24J. After the shunt was examined to ensure its patency, the 
portal vein was carefully separated from hepatic artery and ligated at the 
hepatic hilum to create total PCS. 
2.2. Sample preparation 
One, 2. 4, 7, 15, 30 and 60 days after the creation of PCS, rats were 
weighed and sacrificed (three for each time point). The liver was excised 
alier laparotomy, weighed, rinsed in ice-cold phosphate-buffered saline, 
and processed as follows: a portion of the right lobe was preserved in 
OCT compound (Miles Inc., Elkhart, IN. USA) and a portion in buffered 
formalin. The rest of the liver was snap-frozen in liquid nitrogen. crushed 
and saved in portions at - 80°C. 
2.3. Histological examination and determination of 
apoptosis 
Hematoxylin and eosin-stained sections of the liver were examined for 
histological changes. An ApopTag® peroxidase kit (Intergen Company, 
New York, NY, USA) was used for determination of apoptosis. A total 
of 45-50 fields (about 50 hepatocytes per field) were examined to count 
apoptotic nuclei in the liver sections. 
2.4. Determination of growth mediators 
2.4.1. TGF-f3 
The liver was homogenized in 2.5 volumes of 2.5 N acetic acid contain-
ing 10 M urea, 1 mM phenylmethane sulfonyl fluoride (PMSF) and 10 fLg/ 
ml pepstatin A. After 20 min at room temperature, the pH was adjusted to 
7.4 with 2.7 N NaOHII M N-2-hydroxyethylpiperazinc-NI -2-ethane-sulfo-
nic acid (HEPES). The samples were centrifuged at 20.200 x g for 20 min, 
and the supernatants were used in the enzymc-Iinked immunosorbant assay 
(ELISA; Rand D Systems Inc., Minneapolis, MN, USA) for TGF-i3 quan-
tification. 
2.4.2. HGF 
The liver was homogenized in five volumes of ice-cold Tris-HCl, pH 7.4, 
containing 2 M NaCI, 0.1 % Tween-80, 1 mM PMSF and 1 mM ethy1ene-
diamine-tetraacetic acid (EDT A). The homogenate was centrifuged for 
30 min at 20,000 x g at 4°C, and the supernatant was used in the ELISA 
(R and D Systems). 
2.4.3. TGF-a 
The liver was homogenized in five volumes of 1% trifluoroacetic acid, 
and centrifuged at 17,000 X g for 20 min at 4°C after 2 h at room tempera-
ture for 2 h. The supernatant was applied to C-18 reverse phase column 
(Waters Corp., Milford, MA, USA) pre washed with 2 ml of 60% acetoni-
trile in 1 % trifluoroacetic acid (one wash), and '2 ml of 1% trifluoroacetic 
acid (thrce washes). Following three washes with 1% trifluoroacetic acid, 
TGF-a was eluted with 3 ml 60% acetonitrile in 1% trifluoroacetic acid. 
The organic solvents were dried under N2, and the residual aqueous material 
was lyophilized and reconstituted in radioimmunoassay (RIA) buffer for 
detennination ofTGF-a (Peninsula Laboratories Inc., Belmont, CA, USA). 
2.4.4. ALR 
ALR was extracted and its concentration detennined by ELISA essen-
tially as described previously [18]. 
2.5. Determination ofmRNAfor HGF, TGF-a, TGF-f3 and 
ALR 
Total RNA was isolated using TRI reagent (Molecular Research Center 
Inc .. Cincinnati, OH, USA), and mRNA was extracted using a PolyAT-
tract'" mRNA isolation system (Promega, Madison, WI. USA). Twenty 
micrograms of total RNA (TGF-i3, HGF and ALR) or 3 fLg of the mRNA 
(TGF-a) was denatured at 55°C for 15 min and electrophoresed on a 1% 
agarose/formaldehyde gel and transferred to a Hybond N + membrane 
(Amersham-Phannacia, Piscataway, NJ, USA). The membranes were 
hybridized with 32P-Iabeled cDNA probes in a solution of 50% fOfmamide, 
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5X standard saline citrate (SSC), 10 mM sodium phosphate (pH 6.8), 0.5% 
sodium dodecyl sulfate (SDS). 5X Denhart solution and 20 ILg/ml herring 
sperm DNA at 42°C overnight. The membranes were washed twice with 2X 
SSC containing 0.1 % SDS at room temperature for 30 min, twice with 0.2X 
SSC containing 0.1 % SDS at 55°C for 30 min, and exposed to Kodak 
XOmat film (Eastman Kodak Co., Rochester, NY, USA). The probes 
were radiolabcled by random priming method using multiprime DNA label-
ing kit (Amersham-Pharmacia) in the presence of C2p]dCTP (NEN, 
Boston, MA, USA). A 0.99 kb fragment of rat TGF-(31 cON A was 
purchased from ATCC (Rockville, MD, USA). The eDNA probes for 
HGF, TGF-ry and reduced form of GAPDH were kindly provided by Dr 
George Michalopoulos, Department of Pathology, University of Pittsburgh 
and Drs H. Miyazaki and T. Tsuji, Department of Cellular Biology, 
Okayama University Medical School, Okayama, Japan. GAPDH mRNA 
expression was determined as an internal control. 
2.6. Isolation and culture of hepatocytes 
Hepatocytes were prepared by collagenase digestion of the liver followed 
by purification on a percoll gradient as described previously [25]. Purity 
was determined by immunohistochemical markers for various non-
parenchymal cells and biliary epithelial cells [251. The cells obtained 
thus showed >90')( viablility (trypan blue exclusion) and were more than 
97% pure. Cells were washed twice and suspended in William's medium E 
containing 1. mM L-glutamine, 250 units/ml penicillin. 250 fLg/ml strepto-
mycin. 1 0% fetal bovine serum, 10- 0 M insulin (Eli Lilly Co .. Indianapolis. 
IN, USA) and 20 mM HEPES. Cells were plated in 24-well plates 
(0.125 x 106 cellslwell) and the medium was renewed 3 h later. After over-
night incubation, cells were placed in serum-free William's medium E 
containing 0.1 % bovine semm albumin (BSA), with or without insulin 
and the growth mediators were added at the indicated concentrations. 
Following a 24 h, I'H]thymidine (l f-lCi/ml) was added to the wells and 
incubation was continued for 4 h. The medium was aspirated, the cells 
washed with ice-cold Hanks' balanced salt solution (HBSS) and treated 
with 10'10 icc-cold trichloroacetic acid (TCA) twice before determination 
of TCA-precipitable radioactivity. 
2.7. Statistical analysis 
The results are expressed as averages ± SEM. Statistical significance 
was derived by non-parametric Mann-Whitney two-tailed variance test 
lIsing an SPSS program. A P value of <0.05 was considered statistically 
significant. 
3. Results 
3.1. Liver/body weight ratio after pes 
There was a rapid decline in liverlbody weight ratio after 
PCS (Fig. lA), most of which had occurred by day 7 with 
only a further 10% decrease by day 60. 
3.2. Hepatocellular apoptosis after pes 
Apoptosis was rarely observed in the control liver. After 
the PCS, there was a rapid increase in the number of apop-
to tic nuclei in hepatocytes that peaked between day 4 and 
day 7, and then declined sharply to the basal level on day 15 
(Figs. IB and 2). A similar pattern was also observed for 
other apoptotic hodies that could not be distinguished as 
hepatocytes. These apoptotic bodies were more numerous 
than hepatocytes at all time points, and their number did not 
return to the control value during the time course of the 
experiment. Necrosis of hepatocytes or non-parenchymal 
cells was not observed at any time except in the arteries 
(see below). 
3.3. Arterial remodeling after pes 
Arterial remodeling was evidenced by endothelial cell 
damage. Unlike the hepatocytes and non-parenchymal 
cells, patchy necrosis, mostly of smooth muscle cells, was 
found in small arteries on day 2 (Fig. 3). Necrosis was 
reduced on day 4, and by day 7, there was thickening of 
arterial walls and some increase in the size of the lumens 
that persisted throughout the time course of the experiment 
(Fig. 3). These observations are consistent with earlier 
descriptions of thickened arterioles and compensatory 
increases in hepatic arterial blood flow in rats with conge-
nital portal-systemic shunts l26]. 
4 
';j 3,5 A 
--o ~ 3 
... 
*,'\1 
-
2.5 
.c: 
CJ) 
.Qj 2 :: 
* * 
~ 1.5 
0 
ED 1 "i:: 
II) 
> 0.5 ::i 
0 
0 10 20 30 40 50 60 
Time after pes (days) 
1/1 50 ~ 
u 45 
0 
iii 40 
c. Apoptotic hepatocytes 
II) 35 
.c: 
0 30 0 Other apoptottic bodies 
0 
0 25 or-
~ 
II) 
u 
~ 15 c: 
* u 
:; 10 g 
c. 5 0 
c. 0 <C 0 20 30 40 50 60 10 
Time after pes (days) 
Fig, 1. (A) Livcrlbody weight ratio and (B) hepatocellular apoptosis at 
successive interval after I)CS. (A) At the indicated times post-pes, the 
rats were sacrificed and the respective weights determined. Values 
represent averages of three determinations ±SEM. *p < 0.001 vs. '0' 
time; 1[P < 0.05 \'s. '7-day' time point. (B) Apoptosis was quantified 
using both TUNEL assay and the morphological manifestations of 
apoptotic figures. Each point represents averages of the values from 
three rats (45-50 fields per section) ±SEM, *p < 0.005 vs. '0' 
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3.4. Hepatic TGF-{3 after pes 
The concentration of TGF-I) mRNA increased at 24 h 
after pes and remained elevated until day IS, but the 
increase was not statistically significant relative to the 
control value (Fig. 4A). The protein concentration of 
TGF-I) increased sharply (140% increase) at 24 h after 
pes, remained at about this level until day IS, before 
declining to the basal value at 30 days (Fig. 4B). 
3.5. Hepatic HGF and TGF-cx after pes 
HGF mRNA levels doubled between days 1 and 4 after 
pes, and declined thereafter to the basal value by day 30 
(Fig. SA). In contrast to the doubling of its mRNA tran-
script, HGF protein increased only about 12% between 
days 1 and 4 after pes (Fig. sB), before rising to 45-50% 
over the basal va'lue between days 7 and I S. Return to the 
basal level occurred by postoperative day 60. 
The concentration ofTGF-cx mRNA decreased somewhat 
after pes and did not return to the normal, even on day 60 
(Fig. 6A). However, the decrease was not statistically signif-
icant compared to the conlrol. Paradoxicall y, TGF-cx protei n 
concentration doubled by 4 days, and decreased to the basal 
level by day 30 (Fig. 6B). 
3.6. Hepatic ALR after pes 
ALR mRNA concentration declined, but not signifi-
cantly, after pes for 4 days, and returned to the normal 
Fig. 2. Histopathology showing hepatoceUular apoptosis after pes The sections were processed for TUNEL assay to demonstrate apoptosis. In 
addition to their presence in the parenchymal cells (green arrows), apoptotic bodies that cannot be distinguished as belonging to any specific cell type 
(red arrows) were also observed from day 2 (B). (e) day 4; (D) day 7; (F) da)' 30. Hematoxylin/eosin-stained section of the liver on day 7 after pes (E) 
demonstrates removal of apoptosic cells by 'dropout'. On day 30, apoptotic bodies were found very rarely. Original magnification x 400. 
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Fig. 3. Histopathology showing arterial remodeling after PCS. Sections of the normal liver (A) and of the livers on day 1 (8),2 (C), 4 (D), 7 (E) and 30 
(F) after pes are shown. On day I, edema associated with minimal macrophage infiltration was noted in periarterial space around some hepatic 
arteries. On day 2, the edema was decreased and macrophage infiltration became more evident. Patch)' necrosis, predominantly of the smooth muscle 
cells was also seen (red arrows). Necrosis was minimal on day 4 (D), and thickening of the arterial walls due to smooth muscle cell proliferation (green 
arrows) and macro phage accumulation around the arteries occurred. On day 7, macrophage accumulation was minimal, but thickness of the arterial 
wall was sti ll signi ficantly increased due to increase in smooth muscle cells. The latter showed high number of mitotic figures (green arrows, inset) . 
Arterial morphology was similar and close to normal on days 30 and 60 (not shown), except that the walls were thicker and the lumen size increased. 
Original magnification x 400. 
level by day 10 (Fig. 7 A). In contrast to its mRNA tran-
script, ALR protein increased by 440/0 at 24 h before gradu-
ally declining to the basal value by day 15 (Fig. 7B). 
Changes in hepatic concentration of ALR protein without 
significant alterations in its mRNA expression have been 
reported previously [18]. 
Interestingly, the mRNA express ion of all of these media-
tors, with the exception of TGF-a, was somewhat lower 
than the control value on day 30 although it was still 
above or at near normal levels on day 15 and day 60. The 
si gnificance of thi s finding is unclear since the correspond-
ing protein concentration did not exhibit s imilar trends. 
3.7. Effect of TCF- {3 on HCF-induced DNA synthesis 
In cultu red hepatocy tes TGF-13 completely inhibited 
HGF-stimulated e H]thymidine incorporation, both in the 
presence and absence of insulin (Table 1). These results 
are similar to those described by Nakamura et al. [27]. 
4. Discussion 
The liver of rats previously subjected to PCS retains its 
capacity to regenerate after PH, but only to the preexisting 
shrunken size caused by the portal diversion [6 ,28]. Regen-
eration is itself hepatotrophic in that g lycogen and hepato-
cyte size as well as a variety of organelles temporaril y 
normalize when PH is performed on the atrophic Eck fi stul a 
liver, but only during the period of regenera tion [29]. More-
over, a full recovery (including its weight) of the liver that 
has undergone PCS-induced atrophy, occurs promptly after 
restoration of normal portal venous blood circulation 
[30,31]. The results of such experiments have suggested 
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that endogenously produced extra-hepatic growth factors. of 
which insulin is the most readily identifiable [10,12.32], are 
essential for the maintenance of hepatic size. structure and 
function. Other studies have shown that these same factors 
are required for maintenance of the full capacity for regen-
eration, but not of regeneration per se [29.33.34]. 
In screening for candidate growth modulating factors by 
infusing test substances directly into the tied off central 
portal vein. two growth inhibitory (antihepatotrophic) 
factors have been identified that make the hepatocyte atro-
phy of the pes liver more extreme and inhibit its character-
istic low-grade hyperplasia: qdc-~ fll,13J and the T cell-
directed immunosuppressant rapamycin [35]. In contrast to 
the potentially artifactual conditions of the pes infusion 
experiments (e.g. excessive doses of the test molecules). 
the studies reported here were of the physiologic expression 
of endogenous growth modulating peptides after pes in 
rats. with particular reference to qdc-~K The protein 
concentration of the assayed growth mediators (i.e. HGF, 
TGF-a, ALR and TGF-I3) increased in a time-dependent 
manner. The increases were of lesser magnitude and of 
longer duration than those that have been reported after 
PH [7.8,14-17,19]. and did not correlate precisely with 
the cOiTesponding changes in the respectivc mRNA tran-
scripts. It is likely that for such small increases in the protein 
concentrations enhanced translational activity may be 
adequate, and similar increases in the mRNA levels are 
not necessary. Alternatively, stabilization of the mRNA 
may be a mechanism of smaller increases of the protein 
expression of the growth mediators after pes. Despite 
increases in the hepatotrophic peptides. the liver underwent 
atrophy and apoptosis that correlated with the prompt and 
sustained increase in qdc-~K In several animal models, 
including the rat, pes causes low-grade hyperplasia that 
stabilizes after 4-7 days after the operation [3 J. Therefore, 
near stabilization of the liver size 15 days after pes suggests 
that the two processes (apoptosis and hyperplasia) may have 
reached equilibrium. 
It has been shown that primary cultures of hepatocytes 
exposed to qdc-~ [20-22] and activin A [23] (a member of 
the TGF-13 superfamily), undergo apoptotic death and that 
activin A administration causes significant cell loss from 
apoptosis localized primarily around the central vein in 
rodent livers [23]. Moreover, TGF-fj also induces apoptosis 
of non-parenchymal cells (e.g. the stellate cells [361). 
The strong antagonism of TGF-a actions by TGF-13 has 
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been unequivocally established in in vivo models [7,8,19] 
including PCS [11,131. Moreover, although HGF has been 
reported to protect several cell types including hepatocytes 
from apoptotic death [37-41], it does not protect cultured 
fetal hepatocytes from TGF-[3-induced apoptosis [42], and it 
was found to be proapoptotic for certain cells such as Math 
A mouse sarcoma cells [43], aflatoxin-transformed rat liver 
epithelial cells [44] and hepatoma HepG2 cells [45J. There 
is also considerable in vitro evidence that HGF-stimulated 
DNA synthesis in hepatocytes is completely inhibited by 
TGF-[3 both in the presence and absence of insulin [27] 
(Table 1). Coinfusion ofTGF-[3 with a vaJiety of exogenous 
growth factors in previous studies of PCS could override the 
hepatotrophic effects only ofTGF-a [11,131. However, the 
weight of collective evidence including the studies of PCS 
reported here suggests that the apoptotic effect of TGF-[3 
can overwhelm otherwise physiologically significant 
increases in hepatic tissue concentrations of TGF-a as 
well as HGF and ALR. 
Recently, it was reported that the IL-l[3 mRNA concen-
tration increases 24 h after PCS in rat r 46]. It was suggested 
that the antiproliferative property of IL-I[3 [47] may be 
primarily responsible for the liver atrophy since TGF-[3 
mRNA did not change at this time. However, the protein 
concentrations of these molecules were not determined, and, 
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therefore, it is difficult to speculate on the role of IL-l [3 in 
PCS. In this regard, it should be noted that IL-l [3 has also 
been found to exert no effect on hepatocyte proliferation 
[48], and in yet other studies it was found to be antiapoptotic 
[49,50]. Thus a careful analysis of IL-l[3 (mRNA and 
protein) with respect to the changes of PCS, warrants further 
investigation. 
Table 1 
Etrect of TGF-p on HGF-induced ,.1H]thymidine incorporation in 
hepatocytes" 
- Insulin + Insulin 
Vehicle 318 ± 34 494 ± 53 
HGF (25 ng/ml) 983 ± 73 1331 ± 128 
TGF-J3 (5 ng/ml) 140 ± 24 89 ± 5 
HGF+TGF-J3 113 ± 6 109 ± 2 
Serum (5%) 940 ± 14 932 ± IS 
a After an overnight culture, cells were placed in serum-free medium with 
or without 10 6 M insulin. Growth mediators were added at the concentra-
tion indicated and incubation was continued for 24 h. [1Hjthymidine 
(1 f.1Ci/ml) was added to all wells and the reaction was terminated after 
4 h. Results are expressed as CPMlwell ± SEM of triplicate determinations 
of an experiment performed twice. 
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The actual loss of hepatocytes due to apoptosis probably 
is much higher than could be demonstrated decisively in our 
study. At the 7 -day time point, some apoptotic hepatocytes 
could be seen in the sinusoidal lumen presumably just 
before their removal from the liver by a phenomenon 
known as 'dropout' that has been demonstrated in human 
patients undergoing liver allograft rejection [51-54]. With 
anti-Fas antibody it appeared that the dead hepatocytes 
'leaked out' rather than being phagocytosed by neighboring 
macrophages and granulocytes [55]. Because we did not 
observe any evidence of phagocytosis of apoptotic hepato-
cytes by macrophages, these cells would have been 
excluded from the apoptotic counts. In addition, apoptotic 
bodies that could not be identified, but followed similar 
pattern as for apoptotic hepatocytes were also noted in the 
liver after PCS. The precise identification of these bodies 
could not be made because of the rapidity of the apoptotic 
process and the limitations of TdT-mediated dUTP nick end 
labeling (TUNEL) assay and other procedures [56J. 
In conclusion, the results of this study demonstrate that 
the hepatic atrophy that results [rom PCS occurs despite the 
upregulation of endogenously produced growth promoters 
whose effect appeared to be interdicted by growth inhibitory 
mechanisms of which the physiologic action of TGF-[3 is 
the most obvious candidate. TGF-[3-induced apoptosis of 
liver cells appears to be an integral part of the complex 
mechanism that constrains liver cell and non-parenchymal 
cell replication, allowing a stable equilibrium to be estab-
lished after PCS of low-grade hyperplasia despite global 
organ atrophy. The results may have direct clinical implica-
tions in liver diseases involving portal vein obliteration. 
Ischemia caused by this condition has been shown to 
cause hepatocellular apoptosis and liver atrophy in the 
absence of chronic inflammation [57] 
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